According to Rain Therapeutics's latest financial reports the company has $77.32 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.13 B | -6.96% |
2021-12-31 | $0.14 B | 138.21% |
2020-12-31 | $58.86 M | 915.93% |
2019-12-31 | $5.79 M |